Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B™ vaccine - VBI Vaccines

Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B™ vaccine

January 1, 2004 |

Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B™ vaccine
Medical Science Monitor
January 2004

View More

June 7, 2023

VBI Vaccines Announces Poster Presentation at EASL 2023

May 15, 2023

VBI Vaccines Reports First Quarter 2023 Financial Results

April 25, 2023

VBI Vaccines Appoints Vaughn Himes to Board of Directors

April 4, 2023

VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI